770
Participants
Start Date
August 25, 2025
Primary Completion Date
May 15, 2026
Study Completion Date
May 15, 2026
Flu mRNA (Formulation A)
One dose of Flu mRNA (Formulation A) received intramuscularly.
Flu mRNA (Formulation B)
One dose of Flu mRNA (Formulation B) received intramuscularly.
Comparator 1
One dose of Comparator 1 received intramuscularly.
Comparator 2
One dose of Comparator 2 received intramuscularly.
Comparator 3
One dose of Comparator 3 received intramuscularly.
RECRUITING
GSK Investigational Site, Rochester
RECRUITING
GSK Investigational Site, Newport News
RECRUITING
GSK Investigational Site, Greensboro
RECRUITING
GSK Investigational Site, North Charleston
RECRUITING
GSK Investigational Site, Atlanta
RECRUITING
GSK Investigational Site, Hialeah
RECRUITING
GSK Investigational Site, Miami
RECRUITING
GSK Investigational Site, Jupiter
RECRUITING
GSK Investigational Site, Anniston
RECRUITING
GSK Investigational Site, Cleveland
RECRUITING
GSK Investigational Site, Valparaiso
RECRUITING
GSK Investigational Site, Lenexa
RECRUITING
GSK Investigational Site, DeSoto
RECRUITING
GSK Investigational Site, Fort Worth
RECRUITING
GSK Investigational Site, Austin
RECRUITING
GSK Investigational Site, Carson City
RECRUITING
GSK Investigational Site, San Diego
RECRUITING
GSK Investigational Site, San Diego
RECRUITING
GSK Investigational Site, Walnut Creek
RECRUITING
GSK Investigational Site, Fair Oaks
RECRUITING
GSK Investigational Site, Seattle
RECRUITING
GSK Investigational Site, Springfield
Lead Sponsor
GlaxoSmithKline
INDUSTRY